COURTNEY COCHRAN: Open Payments
NPI 1003574286 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 16 payments from 6 companies in 2025. Trend: 2023 $143 · 2024 $367 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $161 |
| GENZYME CORPORATION | 8 | $141 |
| Medtronic, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| AERIN MEDICAL INC. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: DUPIXENT, NUCALA, PROPEL, TEZSPIRE, VIVAER STYLUS.
Industry payments across CO — which companies pay providers there.
